Vertex Pharmaceuticals (NASDAQ:VRTX) Downgraded to “Hold” Rating by Leerink Partnrs
Vertex Pharmaceuticals (NASDAQ:VRTX – Get Free Report) was downgraded by Leerink Partnrs from a “strong-buy” rating to a “hold” rating in a research note issued on Tuesday,Zacks.com reports. Several other research analysts have also issued reports on the company. Leerink Partners reiterated a “market perform” rating and issued a $503.00 price target (down previously from […]
Vertex Pharmaceuticals (NASDAQ:VRTX – Get Free Report) was downgraded by Leerink Partnrs from a “strong-buy” rating to a “hold” rating in a research note issued on Tuesday,Zacks.com reports. Several other research analysts have also issued reports on the company. Leerink Partners reiterated a “market perform” rating and issued a $503.00 price target (down previously from […]
